DRUG PROFILE

1. Drug:

2. Active ingredient: _____________________________________________

3. Drug category (Prescription/ OTC):_____________________________

4. PRODUCT DESCRIPTION

Sr. Dosage Pack

Brand name Manufacturer Strength Price/unit
no form size
 5. CLINICAL PHARMACOLOGY:

Pharmacological class

Therapeutic class

Mechanism of action

Spectrum (in case of

antibiotics)

Contraindications

Precautions

FDA pregnancy category

6. Clinically Monitoring Parameters:

__________________________________________________________________
__________________________________________________________________
________________________________________________________________

7. Dosage schedule:

Recommended Dosage Duration

Route of
Sr. no Indication of Therapy
Administration Child Adult
(if any)

8. Adjustment of Dosage (if required) in Renal / Hepatic impairment:

__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
_______________________________________________________________
 9. Side effects:

__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
_____________________________________________________________

10. Drug- Drug interaction:

Interacting drug mechanism Outcome Management

s
 11. Drug –Food interaction:
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
__________________________________________________________

12.Toxicology

Signs and Symptoms of Management/Treatment

Toxic Dose
Toxicity (including Antidote)

13. Patient counseling :

__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
_______________________________________________________________